vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $13.8M, roughly 1.0× FENNEC PHARMACEUTICALS INC.). On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 19.9%). Over the past eight quarters, CB Financial Services, Inc.'s revenue compounded faster (1.2% CAGR vs -26.3%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
CBFV vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $13.8M |
| Net Profit | — | $-4.8M |
| Gross Margin | — | — |
| Operating Margin | 38.1% | -18.5% |
| Net Margin | — | -34.7% |
| Revenue YoY | 19.9% | 73.8% |
| Net Profit YoY | — | -141.1% |
| EPS (diluted) | $0.90 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.8M | ||
| Q3 25 | $2.4M | $12.5M | ||
| Q2 25 | $13.5M | $9.7M | ||
| Q1 25 | $12.1M | $8.8M | ||
| Q4 24 | $13.2M | $7.9M | ||
| Q3 24 | $12.7M | $7.0M | ||
| Q2 24 | $12.2M | $7.3M | ||
| Q1 24 | $13.5M | $25.4M |
| Q4 25 | — | $-4.8M | ||
| Q3 25 | $-5.7M | $-638.0K | ||
| Q2 25 | $3.9M | $-3.2M | ||
| Q1 25 | $1.9M | $-1.2M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | $3.2M | $-5.7M | ||
| Q2 24 | $2.6M | $-5.6M | ||
| Q1 24 | $4.2M | $12.8M |
| Q4 25 | 38.1% | -18.5% | ||
| Q3 25 | -289.8% | -1.5% | ||
| Q2 25 | 35.0% | -28.3% | ||
| Q1 25 | 19.3% | -9.2% | ||
| Q4 24 | 23.1% | -11.8% | ||
| Q3 24 | 31.2% | -74.6% | ||
| Q2 24 | 26.4% | -69.4% | ||
| Q1 24 | 37.9% | 54.2% |
| Q4 25 | — | -34.7% | ||
| Q3 25 | -235.2% | -5.1% | ||
| Q2 25 | 29.3% | -32.7% | ||
| Q1 25 | 15.8% | -13.3% | ||
| Q4 24 | — | -25.0% | ||
| Q3 24 | 25.3% | -82.2% | ||
| Q2 24 | 21.8% | -76.5% | ||
| Q1 24 | 31.1% | 50.6% |
| Q4 25 | $0.90 | $-0.17 | ||
| Q3 25 | $-1.07 | $-0.02 | ||
| Q2 25 | $0.74 | $-0.11 | ||
| Q1 25 | $0.35 | $-0.04 | ||
| Q4 24 | $0.45 | $-0.02 | ||
| Q3 24 | $0.60 | $-0.21 | ||
| Q2 24 | $0.51 | $-0.20 | ||
| Q1 24 | $0.82 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $35.5M |
| Total Assets | $1.5B | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $36.8M | ||
| Q3 25 | $55.9M | $21.9M | ||
| Q2 25 | $64.5M | $18.7M | ||
| Q1 25 | $61.3M | $22.7M | ||
| Q4 24 | $49.6M | $26.6M | ||
| Q3 24 | $147.3M | $40.3M | ||
| Q2 24 | $142.6M | $43.1M | ||
| Q1 24 | $73.7M | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $157.5M | $35.5M | ||
| Q3 25 | $152.5M | $-4.5M | ||
| Q2 25 | $148.4M | $-7.5M | ||
| Q1 25 | $148.3M | $-5.9M | ||
| Q4 24 | $147.4M | $-5.9M | ||
| Q3 24 | $149.1M | $-5.2M | ||
| Q2 24 | $142.9M | $-1.4M | ||
| Q1 24 | $141.6M | $3.0M |
| Q4 25 | $1.5B | $70.6M | ||
| Q3 25 | $1.5B | $49.3M | ||
| Q2 25 | $1.5B | $44.9M | ||
| Q1 25 | $1.5B | $46.4M | ||
| Q4 24 | $1.5B | $44.9M | ||
| Q3 24 | $1.6B | $58.9M | ||
| Q2 24 | $1.6B | $63.2M | ||
| Q1 24 | $1.5B | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-6.0M |
| Free Cash FlowOCF − Capex | $17.2M | — |
| FCF MarginFCF / Revenue | 124.1% | — |
| Capex IntensityCapex / Revenue | 4.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-6.0M | ||
| Q3 25 | $4.6M | $1.5M | ||
| Q2 25 | $4.1M | $-3.7M | ||
| Q1 25 | $4.0M | $-4.3M | ||
| Q4 24 | $6.8M | $-1.5M | ||
| Q3 24 | $3.1M | $-2.2M | ||
| Q2 24 | $-1.2M | $-8.4M | ||
| Q1 24 | $3.3M | $39.0M |
| Q4 25 | $17.2M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 124.1% | — | ||
| Q3 25 | 186.5% | — | ||
| Q2 25 | 28.8% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 17.4% | — | ||
| Q2 24 | -19.6% | — | ||
| Q1 24 | 17.0% | — |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 25.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 10.0% | — | ||
| Q1 24 | 7.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.44× | — | ||
| Q1 24 | 0.78× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
